1. Home
  2. PROF vs SCD Comparison

PROF vs SCD Comparison

Compare PROF & SCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROF
  • SCD
  • Stock Information
  • Founded
  • PROF N/A
  • SCD 2003
  • Country
  • PROF Canada
  • SCD United States
  • Employees
  • PROF N/A
  • SCD N/A
  • Industry
  • PROF Medical/Dental Instruments
  • SCD Trusts Except Educational Religious and Charitable
  • Sector
  • PROF Health Care
  • SCD Finance
  • Exchange
  • PROF Nasdaq
  • SCD Nasdaq
  • Market Cap
  • PROF 149.7M
  • SCD 272.7M
  • IPO Year
  • PROF N/A
  • SCD N/A
  • Fundamental
  • Price
  • PROF $5.96
  • SCD $15.56
  • Analyst Decision
  • PROF Strong Buy
  • SCD
  • Analyst Count
  • PROF 2
  • SCD 0
  • Target Price
  • PROF $11.50
  • SCD N/A
  • AVG Volume (30 Days)
  • PROF 31.2K
  • SCD 62.6K
  • Earning Date
  • PROF 08-07-2025
  • SCD 01-01-0001
  • Dividend Yield
  • PROF N/A
  • SCD 9.63%
  • EPS Growth
  • PROF N/A
  • SCD N/A
  • EPS
  • PROF N/A
  • SCD N/A
  • Revenue
  • PROF $11,862,000.00
  • SCD N/A
  • Revenue This Year
  • PROF $71.17
  • SCD N/A
  • Revenue Next Year
  • PROF $134.25
  • SCD N/A
  • P/E Ratio
  • PROF N/A
  • SCD N/A
  • Revenue Growth
  • PROF 75.01
  • SCD N/A
  • 52 Week Low
  • PROF $3.90
  • SCD $11.33
  • 52 Week High
  • PROF $11.42
  • SCD $15.87
  • Technical
  • Relative Strength Index (RSI)
  • PROF 50.91
  • SCD 48.36
  • Support Level
  • PROF $5.79
  • SCD $15.58
  • Resistance Level
  • PROF $6.22
  • SCD $15.97
  • Average True Range (ATR)
  • PROF 0.30
  • SCD 0.28
  • MACD
  • PROF -0.07
  • SCD 0.01
  • Stochastic Oscillator
  • PROF 22.40
  • SCD 66.33

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

About SCD LMP Capital and Income Fund Inc.

Lmp Capital & Income Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is total return with an emphasis on income. The fund invests in a broad range of equity and fixed-income securities of both the U.S. and foreign issuers. Its long-term investments consists of investments in common stocks, convertible preferred stocks, investments in underlying funds and master limited partnerships. Maximum investment in Sales in the IT sector, Cheniere Energy in the energy sector, Ares Management and U.S. Bancorp in the financials sector and Lennar in the consumer discretionary sector, and etc.

Share on Social Networks: